$21.84 $0.10 per serving
Product analysis
Double Strength Ginkgo Biloba 120 mg combines ginkgo’s possible attention-related role with eleuthero’s fatigue-related use. Everyday concentration benefits remain uncertain, and missing extract details make preparation comparisons harder.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
Ginkgo components are named, but its preparation quality remains uncertain. Eleuthero lacks a specific form or plant-part description, limiting comparisons with other extracts.
Ingredient Transparency65
Both ingredient amounts are stated. Missing ginkgo component proportions and an unspecified eleuthero form prevent a complete preparation comparison.
Value For Money62
The selected serving is inexpensive when considering eleuthero. Value for the ginkgo contribution remains uncertain, so that does not settle the value of the whole combination.
Customer Satisfaction94
Customer feedback is strongly positive across a very large number of ratings. That gives a broad picture of buyer satisfaction, without establishing cognitive effects.
Product Focus58
Two ingredients keep the formula easy to follow. Support for everyday attention and productivity is mixed or limited, despite the clear cognitive theme.
- Format
Capsule - Container
- 200 Capsule(s)
- Per serving
- $0.10
- Also available
Double Strength Ginkgo Biloba 120 mg$10.76- Customer rating
- 4.8 · 37,449 ratings
Goals
Impact
Moderate effect
Impact
Moderate effect
Impact
Moderate effect
Impact
Moderate effect
Eleuthero · 250 mgEleuthero · 250 mg
Eleuthero Not classified
No linked studies yet.
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones) | 120 mg | |
organic Eleuthero | 250 mg |
Ginkgo (Ginkgoflavonglycosides, Terpene Lactones) · 120 mg OverallScore71
Double Strength Ginkgo Biloba 120 mg provides 120 mg of ginkgo leaf extract per serving. The leaf extract has a 50:1 extract ratio and lists 6% terpene lactones, but its flavone percentage is unknown. A ginkgolic acid limit is unknown, and the available information does not establish its value for ginkgo.
How this ingredient is rated
Composition and Label Disclosure42
The leaf extract has a 50:1 extract ratio and lists 6% terpene lactones, but its flavone percentage is unknown. No ginkgolic acid limit is available.
Marker and Preparation Disclosure
The leaf extract has a 50:1 extract ratio and lists 6% terpene lactones, but its flavone percentage is unknown.
Declared Ginkgolic Acid Limit
A ginkgolic acid limit is not available, so the limit cannot be established.
Composition and Label Disclosure100
The serving specifies 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
The amount and source are stated: 120 mg of ginkgo leaf extract per serving.
Commercial Price and Usability
Ginkgo value is not established here.
Eleuthero · 250 mg OverallScore60
The serving provides 250 mg of Eleuthero at a low cost per serving. The plant part, preparation and eleutheroside content are unspecified.
How this ingredient is rated
Composition and Label Disclosure0
The available information does not specify the plant part, preparation, or eleutheroside content.
Eleutheroside Marker Disclosure
The available information does not specify eleutheroside content or an extract ratio.
Target Plant-Part Identification
The plant part is not specified in the available information.
Composition and Label Disclosure100
The serving lists 250 mg of Eleuthero.
Eleuthero Amount Disclosure
The amount of Eleuthero per serving is stated as 250 mg.
Commercial Price and Usability100
The cost per serving is low.
Selected-Serving Price Comparison
The cost per serving is low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
- Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.